Mountain Valley MD
Developing the World’s Leading Medicinal Cannabis Ecosystem
To develop and optimize the world’s leading medicinal cannabis ecosystem.
Leveraging our core strengths in cultivation, R&D, processing, manufacturing and marketing with strategic acquisitions and partnerships, we are generating a market-leading global portfolio of leading edge, high quality, vertically-integrated, sustainable medicinal cannabis assets.
Cannabidiol - CBD
Cannabidiol or CBD, is the most abundant non-psychoactive cannabinoid found in cannabis. CBD is the leading option for those who are looking for a natural alternative to prescription or over-the-counter drugs without the mind-altering effects traditionally associated with marijuana or certain pharmaceutical drugs. Cannabidiol has been identified to relieve stiffness, chronic pain, anxiety, depression, neurological disorders, and more, and is in active evaluation for its positive impact to prevent diabetes and the spread of cancer. (healthline.com)
Across our strain genetics, cultivation, extraction and delivery sciences, MVMD prioritizes investment opportunities on disruptive technologies on the leading-edge of transforming the cannabis industry.
Mountain Valley MD is working in cannabinoid product innovation, research and development to formulate therapeutic-grade medicinal cannabis-derived nutraceutical and natural health products.
We are achieving low cost, high yield cultivation leadership out of our Colombia asset, while preserving our focus on craft-grown quality.
Key Growth Pillars
MVMD is working on acquisitions and partnerships that will allow for the advancement in each the business plan pillars as outlined.
Founded on our origins in British Columbia, Canada, our focus is on the science of high- quality craft-grown cannabis aligned with the lowest production cost in the world through our Colombia cultivation assets.
We extract cannabis compounds through advanced Nano detection, appropriation and purification at a 1/10th of the speed, fraction of the costs, with best material loss ratios in the industry.
Advanced desiccated liposome patent portfolio enables compressible delivery formulations for transmucosal delivery that provide quick onset, precision dosing and enhanced bioavailability. Targeting pain, weight loss, energy, focus, sleep, anxiety and more.
Our international partners are strategically sourced and invested in to enable us to access local market capabilities and expertise while creating scale across our global network.
“The global cannabis industry is in the early innings of a major growth cycle and new markets are opening all over the globe.”
“It is rare for new industries to emerge as rapidly as the cannabis sector has and even less common for Canadian enterprises to find themselves with a huge lead on foreign competition. International cannabis markets beckon Canadian LPs, who enjoy an abundance of capital and have the distinct advantage of operating in the world’s first fully legalized domestic marketplace.”
Pricewaterhouse Coopers LLP (PwC)
"Canada is poised to become the world leader in the growing cannabis industry. That potential I've never seen in my investment lifetime."
The global cannabis market:
An unprecedented opportunity.